Pharmacological approach to wheezing in preschool children

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2014-04-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14656566.2014.896340PMID 24611506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• わが国における成人市中肺炎原因微生物についてのsystematic review/meta‐analysis

  2016cited by this paper
• Lower Respiratory Tract Infections Associated with Rhinovirus during Infancy and Increased Risk of Wheezing during Childhood. A Cohort Study

  2013cited by this paper
• Prednisolone reduces recurrent wheezing after first rhinovirus wheeze: a 7‐year follow‐up

  2013cited by this paper
• Macrolides for the long‐term management of asthma – a meta‐analysis of randomized clinical trials

  2013cited by this paper
• Growth of preschool age children receiving daily inhaled corticosteroids.

  2013cited by this paper
• Recurrent lower respiratory tract infections in children: a practical approach to diagnosis.

  2013cited by this paper
• Wheezing in preschool children

  2013cited by this paper
• Is Asthma an Infectious Disease? New Evidence

  2013cited by this paper
• A review on leukotrienes and their receptors with reference to asthma

  2013cited by this paper
• Phenotype‐directed treatment of pre‐school‐aged children with recurrent wheeze

  2012cited by this paper
• Novel severe wheezy young children phenotypes: boys atopic multiple-trigger and girls nonatopic uncontrolled wheeze.

  2012cited by this paper
• Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.

  2012cited by this paper
• Predicting who will have asthma at school age among preschool children.

  2012cited by this paper
• Daily or intermittent budesonide in preschool children with recurrent wheezing.

  2011cited by this paper
• Steroid responsiveness and wheezing phenotypes

  2011cited by this paper
• No efficacy of prednisolone in acute wheezing associated with human bocavirus infection.

  2011cited by this paper
• Allergic Sensitization Is Associated With Rhinovirus-, but not Other Virus-, Induced Wheezing in Children

  2011cited by this paper
• Allergic sensitization is associated with rhinovirus‐, but not other virus‐, induced wheezing in children

  2010cited by this paper
• The Management of Pre-School Wheeze

  2010influential reference
• Viruses and bacteria in acute asthma exacerbations – A GA2LEN‐DARE* systematic review

  2010cited by this paper
• Preemptive use of high-dose fluticasone for virus-induced wheezing in young children.

  2009cited by this paper
• Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study

  2009cited by this paper
• Efficacy of Inhaled Corticosteroids in Infants and Preschoolers With Recurrent Wheezing and Asthma: A Systematic Review With Meta-analysis

  2009cited by this paper
• Preemptive Use of High-Dose Fluticasone for Virus-Induced Wheezing in Young Children

  2009cited by this paper
• Safety and tolerability of montelukast in placebo‐controlled pediatric studies and their open‐label extensions

  2009cited by this paper
• Oral prednisolone for preschool children with acute virus-induced wheezing.

  2009cited by this paper
• Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach

  2008cited by this paper
• Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial.

  2008cited by this paper
• Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing.

  2008influential reference
• Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood

  2008cited by this paper
• Exhaled nitric oxide distinguishes between subgroups of preschool children with respiratory symptoms.

  2008cited by this paper
• Secondary Prevention of Asthma by the Use of Inhaled Fluticasone Propionate in Wheezy Infants (IFWIN): Double-Blind, Randomised, Controlled Study

  2007influential reference
• Short-course montelukast for intermittent asthma in children: a randomized controlled trial.

  2007cited by this paper
• Parent‐initiated oral corticosteroid therapy for acute asthma: A survey of current practice

  2007cited by this paper
• Atopic characteristics of wheezing children and responses to prednisolone

  2007cited by this paper
• Efficacy of prednisolone in children hospitalized for recurrent wheezing

  2007cited by this paper
• Prevalence of asthma‐like symptoms in young children

  2007cited by this paper
• The Association Between Respiratory Syncytial Virus Infection and the Development of Childhood Asthma: A Systematic Review of the Literature

  2007cited by this paper
• Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers.

  2007cited by this paper
• Metabolomics applied to exhaled breath condensate in childhood asthma.

  2007cited by this paper
• Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study.

  2006cited by this paper
• Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial.

  2006cited by this paper
• Intermittent inhaled corticosteroids in infants with episodic wheezing.

  2006cited by this paper
• Long-term inhaled corticosteroids in preschool children at high risk for asthma.

  2006cited by this paper
• Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.

  2006cited by this paper
• Evaluation of the Safety and Efficacy of Levalbuterol in 2–5‐year‐Old Patients with Asthma

  2005cited by this paper
• Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma.

  2005cited by this paper
• The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old.

  2005cited by this paper
• Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy

  2005cited by this paper
• Wheeze phenotypes and lung function in preschool children.

  2005cited by this paper
• Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing.

  2004cited by this paper
• Bronchodilation in infants with malacia or recurrent wheeze

  2003cited by this paper
• Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial.

  2003cited by this paper
• Corticosteroids for hospitalised children with acute asthma.

  2003cited by this paper
• Short acting beta agonists for recurrent wheeze in children under 2 years of age.

  2002cited by this paper
• Short acting beta2‐agonists for recurrent wheeze in children under two years of age

  2002cited by this paper
• Systemic activity of inhaled steroids in 1- to 3-year-old children with asthma.

  2002cited by this paper
• Randomized controlled trial of fluticasone in preschool children with intermittent wheeze.

  2002cited by this paper
• Do inhaled corticosteroids inhibit growth in children?

  2001cited by this paper
• Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone

  2001cited by this paper
• Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer.

  2001cited by this paper
• Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections.

  2001cited by this paper
• Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing.

  2000cited by this paper
• Inhaled salbutamol for wheezy infants: a randomised controlled trial

  2000cited by this paper
• Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children.

  2000cited by this paper
• Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants.

  1999influential reference
• The bronchoprotective effect of inhaled salmeterol in preschool children: a dose-ranging study.

  1999cited by this paper
• Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP)

  1999cited by this paper
• Prophylactic intermittent treatment with inhaled corticosteroids of asthma exacerbations due to airway infections in toddlers

  1999cited by this paper
• Bronchodilator responsiveness testing using raised volume forced expiration in recurrently wheezing infants

  1998cited by this paper
• ASTHMA AND WHEEZING IN THE FIRST SIX YEARS OF LIFE

  1996cited by this paper
• Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children.

  1995cited by this paper
• Asthma and wheezing in the first six years of life. The Group Health Medical Associates.

  1995cited by this paper
• Prevention of viral induced asthma attacks using inhaled budesonide.

  1993cited by this paper
• Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness.

  1993cited by this paper
• Systemic activity of inhaled topical steroid in toddlers studied by knemometry

  1993cited by this paper
• Controlled trial of nebulized albuterol in children younger than 2 years of age with acute asthma.

  1992cited by this paper
• The efficacy of nebulized metaproterenol in wheezing infants and young children.

  1992cited by this paper
• Short-term effect of albuterol, delivered via a new auxiliary device, in wheezy infants.

  1991cited by this paper
• Do wheezy infants recovering from bronchiolitis respond to inhaled salbutamol?

  1991cited by this paper
• Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home.

  1990cited by this paper
• Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves.

  1987cited by this paper
• Hypoxaemia in wheezy infants after bronchodilator treatment.

  1987cited by this paper
• Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants.

  1986cited by this paper

• Management of Preschool Wheezing: Guideline from the Emilia-Romagna Asthma (ERA) Study Group

  2022cites this paper
• Risk Factors Affecting Development and Persistence of Preschool Wheezing: Consensus Document of the Emilia-Romagna Asthma (ERA) Study Group

  2022cites this paper
• Prescription patterns of inhaled corticosteroids for preschool children – A Norwegian register study

  2015cites this paper